CDSCO Digital Transformation & May 2026 Compliance Deadlines
CDSCO's unified digital ecosystem launches with May 13 deadline. New AI tools for faster approvals and pending application cleanup underway.
Read MoreRegulatory updates, compliance insights, and industry analysis from the ACPL team.
CDSCO's unified digital ecosystem launches with May 13 deadline. New AI tools for faster approvals and pending application cleanup underway.
Read MoreCDSCO's March 2026 reforms introduce prior intimation for BA/BE studies, reducing approval times from 90 to 45 days for faster…
Read MoreNew rules effective March 7, 2026 cut approval timelines from 90 to 45 days. Prior intimation replaces licenses for low-risk…
Read MoreRecent searches reveal minimal NDPS notifications in Q1 2026, while related pharmaceutical regulations show active enforcement. Key compliance insights.
Read MoreCDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions…
Read More
Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for…
Read More
G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled…
Read More
Let’s be real: in today’s business world, you can’t just ignore compliance. It’s not a box to tick—it’s something you’ve…
Read MoreHighlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and…
Read MoreIndia-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026,…
Read More